SHL Telemedicine Ltd. (NASDAQ:SHLT – Get Free Report)’s stock price was up 8.2% on Wednesday . The stock traded as high as $6.08 and last traded at $6.08. Approximately 827 shares changed hands during trading, a decline of 80% from the average daily volume of 4,041 shares. The stock had previously closed at $5.62.
Analysts Set New Price Targets
Separately, Litchfield Hills Research reissued a “buy” rating and set a $11.00 price objective on shares of SHL Telemedicine in a report on Thursday, March 14th.
Check Out Our Latest Stock Report on SHLT
SHL Telemedicine Trading Up 8.2 %
SHL Telemedicine Company Profile
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center.
Recommended Stories
- Five stocks we like better than SHL Telemedicine
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
- What is Put Option Volume?
- WD-40 Company Greases the Wheels of Growth and Profits
- How to Buy Cheap Stocks Step by Step
- How to Protect your Portfolio Against a Rising VIX
Receive News & Ratings for SHL Telemedicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SHL Telemedicine and related companies with MarketBeat.com's FREE daily email newsletter.